The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer
- PMID: 20567171
- DOI: 10.1097/AOG.0b013e3181e3e719
The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer
Erratum in
- Obstet Gynecol. 2010 Sep;116(3):775-7
Abstract
Background: To estimate the relationship of human papillomavirus (HPV) detection and abnormal cytology with histologic diagnoses of cervical precancer and cancer.
Methods: From 2003 to 2008 we examined the HPV, cytology, and diagnostic results from almost one million cervical cancer screenings done on women aged 30 and older who were members in Kaiser Permanente Northern California, a large health maintenance organization that introduced cotesting in 2003. Women were screened using conventional Pap tests and a DNA test for a pool of 13 high-risk HPV genotypes. Women with HPV-positive atypical squamous cells of undetermined significance and other abnormal cervical cytology, independent of their HPV results, routinely underwent colposcopy. Results were stratified by 5-year age groups from 30 to 64.
Results: High-grade squamous intraepithelial lesions (HSIL), atypical squamous cells, cannot exclude HSIL (ASC-H), and atypical glandular cells were more strongly associated with cervical intraepithelial neoplasia grade 3 while low-grade squamous intraepithelial lesions (LSIL) and HPV-positive atypical squamous cells of undetermined significance were more strongly associated with cervical intraepithelial neoplasia grade 2 (CIN2). Cervical cancer was most commonly found in women with HSIL and atypical glandular cells cytology. Human papillomavirus-negative women with ASC-H cytology were at a reduced but significant risk of CIN2 or more severe (CIN2+) (10.6%) compared with HPV-positive women with ASC-H cytology. Human papillomavirus-negative women with LSIL were at a 4.0% risk of CIN2+, and among women 50 and older, at a 0.5% risk of CIN2+ with no cancers were diagnosed.
Conclusion: Human papillomavirus testing may be useful for triage for colposcopic referral for LSIL cytology in older women but not for ASC-H cytology at any age.
Level of evidence: II.
Similar articles
-
Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.Obstet Gynecol. 2017 Dec;130(6):1218-1225. doi: 10.1097/AOG.0000000000002330. Obstet Gynecol. 2017. PMID: 29112672 Free PMC article. Clinical Trial.
-
The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.Arch Pathol Lab Med. 2003 Aug;127(8):950-8. doi: 10.5858/2003-127-950-TCVROH. Arch Pathol Lab Med. 2003. PMID: 12952506
-
HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.Int J Clin Oncol. 2015 Oct;20(5):974-81. doi: 10.1007/s10147-015-0789-4. Epub 2015 Feb 5. Int J Clin Oncol. 2015. PMID: 25652908
-
Cervical Cancer Screening: A Review.JAMA. 2023 Aug 8;330(6):547-558. doi: 10.1001/jama.2023.13174. JAMA. 2023. PMID: 37552298 Review.
-
Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer.Cancer Cytopathol. 2016 Apr;124(4):261-72. doi: 10.1002/cncy.21661. Epub 2015 Nov 30. Cancer Cytopathol. 2016. PMID: 26618614 Free PMC article. Review.
Cited by
-
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.Geburtshilfe Frauenheilkd. 2019 Feb;79(2):160-176. doi: 10.1055/a-0828-7722. Epub 2019 Feb 18. Geburtshilfe Frauenheilkd. 2019. PMID: 30792546 Free PMC article.
-
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.Lancet Oncol. 2011 Jul;12(7):663-72. doi: 10.1016/S1470-2045(11)70145-0. Epub 2011 Jun 16. Lancet Oncol. 2011. PMID: 21684207 Free PMC article.
-
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543559 Free PMC article.
-
It's time to re-evaluate cervical Cancer screening after age 65.Gynecol Oncol. 2021 Jul;162(1):200-202. doi: 10.1016/j.ygyno.2021.04.027. Epub 2021 Apr 26. Gynecol Oncol. 2021. PMID: 33926748 Free PMC article. Review.
-
Human papillomavirus testing in the prevention of cervical cancer.J Natl Cancer Inst. 2011 Mar 2;103(5):368-83. doi: 10.1093/jnci/djq562. Epub 2011 Jan 31. J Natl Cancer Inst. 2011. PMID: 21282563 Free PMC article. Review.
References
-
- Wright TC Jr, Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 2003;348:489–90.
-
- Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342–62.
-
- Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304–9.
-
- Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114–9.
-
- Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120–9.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous